Member Info for Whackery

In earlier reply, below, I meant 'damaged but undaunted' of course.

Now up over 50% on yesterday's low. Augurs well if this trend continues pre share suspension, getting us closer to 10p - indicative of confidence we'll come through the other end. Damaged but not undaunted. From whence onwards and upwards; baggage-free.

Clutching at straws Sky. RNS states: Whilst progress is being made, this forensic review is ongoing and accordingly, the Company will not be in a position to announce the Interim Results by 31 March 2026, as required by the AIM Rules for Companies.

You could ask him Sky? 🙂

Let me draw bigpunt's query back into focus. Any info/opinions?

Pharm, isn't the cash burn higher than your £10K. per day if you allow that in the period in question there were only some 160 working days (even if the end result is the same). But surely there were sizeable revenues counterbalancing the outflow. Who knows what the spend per working day has been; and the investigation itself is barely under way, leaving us in the dark. Or am I missing something and mis-reading your post? Maybe it's now £20K. per working day, and it won't end this month it seems, else flagging suspension mightn't have been necessary?

Two comments on price rise: investor attention comes our way on many fronts, what with bordering on a 60% 5-day SP bounce measured against a FTSE reversal approaching 5%. Then there's Laura having banked a handsome - was it 70%? - profit on half his/her SBTX holding. Instead of topslicing that's rarely a bad call, having done so, he/she bails out a day or two later when a retention in some measure is now clocking in almost double the gain secured on the initial disposal. I'm not suggesting it's black and white; there's greyness in the air in this debate especially as regards the case in point.

Topslice and then jump - but where to? If SBTX, given its acknowledged up and running USP, were to hit, say £1, won't Laura regret not having retained a bit of the action? Search for another SBTX is it?

In comes acting CEO who, apparently, didn't see too many things she didn't like, out goes Sheedy who, apparently, did; down go the indices, up goes SBTX SP. So far so good.

If only to shut him up, will someone inform Net that 'gleam' can be a noun or a verb. When used as a verb it is intransitive. If he didn't know, this means that you can't 'gleam' something. 'Gleaned', on the other hand, is the right expression to develop his point. As for me, my assertion that 'gleamed' was a typo is suggested (a) by the fact that m and n sit side by side, and (b) you can't 'gleam' something! Apologies for taking up space on pedantics - but I didn't start it. Did I finish it? That is the question. Put that in your Cambridge University Press.

'Dangerous' as in petulant Trump-like name-calling (as though it might somehow score points in intelligent company!) to discredit anyone who calls you out. So maybe not quite so dangerous in the case in point.

Unlike Net, my fellow idiots and plonkers see dangers in AI - the perfect propagandist. Bringing nothing fresh to the table, it is exploitable in reinforcing opinions, predispositions and prejudices; the outcome witnesses Net attempting to influence the uncommitted observer. 'You heard it from the BBC' is the message when, in truth, it was merely 'gleaned', if one understands the nuance. Moving on, let me add 'dangerous' to my earlier 'disingenuous' and (potentially) 'misleading'.

You're on the money Sky (else I too am an idiot and a plonker); it's all in the word 'gleaned' - never mind the typo - check out definition.

'Net' added two and two and got AI to deliver 4. Disingenuous and misleading in any man's language.

Croda list Zenakine in number 1 spot - also references skin fatigue and premature ageing.

· We have ramped up the development of new ingredients with sales increasing by 10% at constant currency. Launches included:

o Zenakine, an active which enhances skin's resistance to physical and emotional stress, thereby reducing skin fatigue and premature ageing, with customer launches in Europe and Asia

Could that £125K spend be the turning point? ; the deed that saved the company? that staved-off share-dealing suspension?

Saw post earlier from Belgrano - now tucked away somewhere. In the same boat Belgrano; not so much a case of 'been there', pal, I WAS there, as indeed was Toyin, when the Ashman hype suckered us in, to our great cost (as yet). US Psoriasis Society partners ready to go, bulging Belgian storage space, Wind-somebody's biggest customer. would-be-partners banging on his door. However in jig time his then side-kick, Financial Controller Doug, bailed 'to pursue other interests' - what an unlikely time to jump ship - just as we were stocking up! Later, as you say, we're told of order-restriction because of demand as indicated by scale of numbers registering. You and I tried to call him out as regards the latter invention. Let's see where it all takes us. Hopefully MD 20% holding is intact

I stand corrected.

SA's promised trading update before end Jan seems the logical answer?

Mr. Ashman missed the boat in not buying-in at 12.5p; would he do himself and the rest of us a favour, a 50% plus rise notwithstanding, by getting off the fence - or does he know better?

'clear answers, accountability on Croda numbers' is it? When might the rest of us get to hear of it? Though that's what all the fuss is about.